Acurx Pharmaceuticals (ACXP) Misses Q2 EPS by 5c

Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.28), $0.05 worse than the analyst estimate of ($0.23).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Investing.com’s stocks of the week
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group